Research ArticleOMERACT 9: International Consensus Conference on Outcome Measures in Rheumatology, Kananaskis Village, Alberta, Canada, May 27–31, 2008
Observations from the OMERACT Drug Safety Summit, May 2008
LEE S. SIMON, C. VIBEKE STRAND, MAARTEN BOERS, PETER M. BROOKS, DAVID HENRY and PETER S. TUGWELL
The Journal of Rheumatology September 2009, 36 (9) 2110-2113; DOI: https://doi.org/10.3899/jrheum.090590
LEE S. SIMON
C. VIBEKE STRAND
MAARTEN BOERS
PETER M. BROOKS
DAVID HENRY
REFERENCES
- 1.↵
- Simon LS,
- Strand CV,
- Boers M,
- et al.,
- 2.↵
- US Food and Drug Administration Advisory Committee
- 3.↵
- 4.
- 5.
- 6.
- Atkins D,
- Best D,
- Briss P,
- et al.,
- the GRADE Working Group
In this issue
The Journal of Rheumatology
Vol. 36, Issue 9
1 Sep 2009
Observations from the OMERACT Drug Safety Summit, May 2008
LEE S. SIMON, C. VIBEKE STRAND, MAARTEN BOERS, PETER M. BROOKS, DAVID HENRY, PETER S. TUGWELL
The Journal of Rheumatology Sep 2009, 36 (9) 2110-2113; DOI: 10.3899/jrheum.090590